文献速递其他结缔组织病

缺氧与TLR9激活通过mtROS和HIF-2α驱动系统性硬化症浆细胞样树突状细胞产生CXCL4

Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该研究探讨系统性硬化症(SSc)中CXCL4产生的机制,将97例健康对照和70例SSc患者的浆细胞样树突状细胞(pDC)在缺氧或常氧条件下培养,并给予TLR激动剂刺激。结果显示,仅缺氧与TLR9激动剂同时作用时CXCL4释放显著增强(P < 0.0001),且该过程依赖线粒体活性氧(mtROS)过度产生(P = 0.0079)和HIF-2α稳定(P = 0.029)。结论提示缺氧下TLR介导的免疫细胞激活促进SSc中CXCL4的致病性产生。

要点

  • 缺氧联合TLR9激动剂刺激使pDC的CXCL4释放显著增强(P < 0.0001)。
  • CXCL4产生依赖mtROS过度产生(P = 0.0079)及HIF-2α稳定(P = 0.029)。
  • 阻断mtROS或HIF-2α通路可能减轻CXCL4对SSc的致病贡献。

核心结论

  • 缺氧环境下TLR介导的免疫细胞激活是SSc中CXCL4致病性产生的基础机制。
  • 阻断mtROS或HIF-2α通路可能治疗性减弱CXCL4对SSc及其他CXCL4驱动炎症性疾病的贡献。

研究设计与样本

  • 研究纳入97例健康对照和70例SSc患者的浆细胞样树突状细胞(pDC),在缺氧或常氧条件下培养并给予多种TLR激动剂刺激。
  • 采用ELISA、Luminex、qPCR、FACS和western blot检测促炎细胞因子、CXCL4、HIF-1α和HIF-2α的基因与蛋白表达。

主要发现

  • 仅当pDC同时暴露于缺氧和TLR9激动剂时CXCL4释放才被增强(P < 0.0001)。
  • CXCL4产生依赖于线粒体活性氧(mtROS)过度产生(P = 0.0079),并导致HIF-2α稳定(P = 0.029)。
  • 缺氧对于脐带CD34来源的pDC产生CXCL4是必需的。

临床怎么用

  • 靶向mtROS或HIF-2α通路可能成为 attenuating CXCL4 致病作用的新策略,用于SSc及其他CXCL4驱动的炎症性疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: SSc is a complex disease characterized by vascular abnormalities and inflammation culminating in hypoxia and excessive fibrosis. Previously, we identified chemokine (C-X-C motif) ligand 4 (CXCL4) as a novel predictive biomarker in SSc. Although CXCL4 is well-studied, the mechanisms driving its production are unclear. The aim of this study was to elucidate the mechanisms leading to CXCL4 production. METHODS: Plasmacytoid dendritic cells (pDCs) from 97 healthy controls and 70 SSc patients were cultured in the presence of hypoxia or atmospheric oxygen level and/or stimulated with several toll-like receptor (TLR) agonists. Further, pro-inflammatory cytokine production, CXCL4, hypoxia-inducible factor (HIF) -1α and HIF-2α gene and protein expression were assessed using ELISA, Luminex, qPCR, FACS and western blot assays. RESULTS: CXCL4 release was potentiated only when pDCs were simultaneously exposed to hypoxia and TLR9 agonist (P < 0.0001). Here, we demonstrated that CXCL4 production is dependent on the overproduction of mitochondrial reactive oxygen species (mtROS) (P = 0.0079) leading to stabilization of HIF-2α (P = 0.029). In addition, we show that hypoxia is fundamental for CXCL4 production by umbilical cord CD34 derived pDCs. CONCLUSION: TLR-mediated activation of immune cells in the presence of hypoxia underpins the pathogenic production of CXCL4 in SSc. Blocking either mtROS or HIF-2α pathways may therapeutically attenuate the contribution of CXCL4 to SSc and other inflammatory diseases driven by CXCL4.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Ottria A, Zimmermann M, Paardekooper LM, et al. Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α. Rheumatology (Oxford). 2022. PMID: 34559222. doi:10.1093/rheumatology/keab532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。